1. Home
  2. DLPN vs HCWB Comparison

DLPN vs HCWB Comparison

Compare DLPN & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.06

Market Cap

14.6M

ML Signal

HOLD

HCWB

HCW Biologics Inc.

HOLD

Current Price

$3.34

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
HCWB
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
14.8M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
DLPN
HCWB
Price
$1.06
$3.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
9.4K
47.6K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
77.87
N/A
EPS
N/A
0.37
Revenue
$56,699,389.00
$4,099,750.00
Revenue This Year
$14.73
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
N/A
$8.65
Revenue Growth
9.70
N/A
52 Week Low
$0.99
$0.25
52 Week High
$1.88
$7.35

Technical Indicators

Market Signals
Indicator
DLPN
HCWB
Relative Strength Index (RSI) 44.96 57.49
Support Level $1.04 $0.37
Resistance Level $1.17 $3.89
Average True Range (ATR) 0.05 0.45
MACD -0.00 -0.11
Stochastic Oscillator 26.67 59.07

Price Performance

Historical Comparison
DLPN
HCWB

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: